Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

Part of paid clinical trials in Baton Rouge, Louisiana.

Sponsor
Pennington Biomedical Research Center
Study ID
NCT05958368
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Avocado — OTHER
    The Hass Avocado group will consume 7 avocados a week (1 / day; \~240 kcals/d).
  • Other Fruit(s) — OTHER
    The other fruits group will consume fruit(s) matched to the avocado in energy and form (i.e., solid fruit).

Study Details

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

Key Dates

Start date
Oct 10, 2023
Status verified
Jul 2025
Primary completion
May 30, 2026
Completion
Dec 15, 2026

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Avocado
    Participants will consume 1 Hass avocado a day.
  • Active Comparator: Other Fruit(s)
    Participants in the other fruit arm will receive other fruits.

Primary Outcome Measure

Fasting Blood Glucose [ Time Frame: Week 5 - Week 0 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Pennington Biomedical Research CenterBaton RougeLouisiana70808
John W Apolzan, PhD
[email protected]
225-763-2827

Find similar trials in Baton Rouge, LA

By condition
Type 2 diabetesObesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Pennington Biomedical Research Center· Baton Rouge, LA

Related Studies